Powerful new COVID vaccine undergoing final trials

Novavax announced its COVID-19 vaccine is over 90% effective against various coronavirus variants, including the original and alpha strains. Unlike mRNA vaccines like Pfizer and Moderna, Novavax uses a traditional method by injecting purified virus proteins to trigger an immune response. This approach involves using a treated version of the virus's spike protein to stimulate antibody production without causing disease.

What new insight or understanding did you gain from this video?